ProImmune

Characterizing adaptive immune responses

General Information
Company Name
ProImmune
Founded Year
2000
Location (Offices)
Oxford, United Kingdom +2
Founders / Decision Makers
Number of Employees
49
Industries
-
Funding Stage
-
Social Media

ProImmune - Company Profile

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. We offer unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen characterization platform, and products and services for tracking antigen-specific immune responses with state-of-the-art ELISpot and flow cytometry techniques. We are committed to helping you take your studies to success through product innovation, responsive service and focused application support, saving you time and money and reducing risk.

Taxonomy: adaptive immune responses, immunology research, antigen characterization, ELISpot, flow cytometry, preclinical research, clinical research, immune response tracking, antigen-specific immune responses, product innovation, application support

Funding Rounds & Investors of ProImmune (0)

View All

There is no investment information

Latest News of ProImmune

View All

No recent news or press coverage available for ProImmune.

Similar Companies to ProImmune

View All
Asylia Therapeutics - Similar company to ProImmune
Asylia Therapeutics Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious diseases.
Immunowake, Inc. - Similar company to ProImmune
Immunowake, Inc. Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery.
Memgen, Inc. - Similar company to ProImmune
Memgen, Inc. Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Asgard Therapeutics - Similar company to ProImmune
Asgard Therapeutics Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy
Duet BioTherapeutics - Similar company to ProImmune
Duet BioTherapeutics A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cancers.